news

Catch up on news from us and the companies we follow

December 12 2018

Oxford BioTherapeutics expands strategic collaboration with WuXi Biologics

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing and Oxford BioTherapeutics Ltd. ("OBT"), a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate based therapies, today announced the expansion of their strategic and innovative immuno-oncology (IO) alliance…

Archive
December 2017